packageTeneligliptin

teneligliptin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Teneligliptin is a DPP-4 inhibitor developed to lower blood glucose in adults with type 2 diabetes. It is not authorised in the European Union and is considered investigational there, though it is used in some Asian countries.

Summary written by glm-5.3-flash from Wikidata Q15269678 and the WHO ATC classification; not checked by a person.

name:teneligliptin
ATC codes:A10BH08
DrugBank:DB11950
PubChem CID:11949652
ChEBI:136042
Wikidata:Q15269678
formula:C22H30N6OS
molar mass:426.583 g/mol (PubChem CID 11949652)
logP:2.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown